NUVB logo

Nuvation Bio Inc. (NUVB)

Profile

Full Name

Nuvation Bio Inc.

Ticker

NYSE: NUVB

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 26, 2020

Indexes

Not included

Website

https://www.nuvationbio.com

Employees

273

Key Details

Price

$3.37(+1.36%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.87M(+100.00% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.37
    NUVB price is $3.37

    30-Day Relative Volume

    1.13
    NUVB 30-day relative volume is 1.13

    Price Performance

    Price Today change

    +1.36%
    NUVB price is up +1.36% today

    Price YTD change

    +26.5%
    NUVB price is up +26.5% since January 1st

    Price 1-year change

    +9.61%
    NUVB price is up +9.61% year-on-year

    Price 3-year change

    +18.49%
    NUVB price is up +18.49% over the past 3 years

    Price Range

    Price All-time high

    $15.23
    NUVB price is currently -77.91% below its historical high of $15.23

    Price 3-year low

    $0.95
    NUVB price is currently +254.21% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.15B
    NUVB market capitalization is $1.15 billion

    Market cap 3-year change

    +85.82%
    NUVB market capitalization is up +85.82% over the past 3 years

    Market cap All-time high

    $3.17B
    NUVB market capitalization is currently -63.68% below its historical high of $3.17 billion

    Market cap sector rank

    73.7%
    NUVB market capitalization is higher than 73.7% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.24%
    NUVB shares outstanding is up +2.24% year-on-year

    Shares Outstanding 3-Year Change

    +56.83%
    NUVB shares outstanding is up +56.83% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.42
    NUVB beta is 1.42

    200-day SMA

    $2.36
    NUVB price is currently +42.63% above its 200-day simple moving average

    50-day SMA

    $2.58
    NUVB price is currently +30.45% above its 50-day simple moving average

    RSI

    60.86
    NUVB 14-day relative strength index is 60.86

    Volume

    1.13
    NUVB 30-day relative volume is 1.13

    ATR

    $0.25
    NUVB average true range is $0.25

    10-day Historical Volatility

    110.04%
    NUVB 10-day historical volatility is 110.04%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $7.87M
    NUVB annual revenue is $7.87 million

    Revenue Analysts estimate

    $36.65M
    NUVB annual revenue is currently -78.52% lower than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    NUVB annual revenue is up +100% year-on-year

    Revenue Sector rank

    46.04%
    NUVB annual revenue is higher than 46.04% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    NUVB annual earnings per share is $0.00

    EPS Analysts estimate

    -$0.55
    NUVB annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    NUVB annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.42%
    NUVB annual earnings per share is higher than 82.42% of companies in Healthcare sector

    Profit

    Gross profit

    $112.00K
    NUVB annual gross profit is $112.00 thousand

    Gross margin

    1.42%
    NUVB annual gross profit margin is 1.42%

    Operating profit

    -$592.63M
    NUVB annual operating income is -$592.63 million

    Operating margin

    -2128.25%
    NUVB annual operating profit margin is -2128.25%

    Net income

    -$567.94M
    NUVB annual net profit is -$567.94 million

    Net margin

    -7213.76%
    NUVB annual net profit margin is -7213.76%

    Expenses

    Total expenses

    $600.50M
    NUVB annual total expenses is $600.50 million

    Operating expenses

    $593.42M
    NUVB annual total operating expenses is $593.42 million

    Cost of goods sold

    $7.76M
    NUVB annual cost of goods sold is $7.76 million

    Selling, general & administrative expenses

    $69.23M
    NUVB annual SGA is $69.23 million

    Depreciation and amortization

    $683.00K
    NUVB annual depreciation & amortization is $683.00 thousand

    Interest expense

    $0.00
    NUVB annual interest expense is $0.00

    Income tax

    $0.00
    NUVB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$567.60M
    NUVB annual earnings before interest & taxes is -$567.60 million

    EBITDA

    -$566.91M
    NUVB annual EBITDA is -$566.91 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $540.63M
    NUVB annual total assets is $540.63 million

    Non current assets

    $14.37M
    NUVB annual long term assets is $14.37 million

    Current assets

    $526.25M
    NUVB annual total current assets is $526.25 million

    Cash and cash equivalents

    $35.72M
    NUVB annual cash & cash equivalents is $35.72 million

    Accounts receivable

    $12.72M
    NUVB annual accounts receivable is $12.72 million

    Inventory

    $0.00
    NUVB annual inventory is $0.00

    Liabilities

    Total liabilities

    $76.84M
    NUVB annual total liabilities is $76.84 million

    Long term liabilities

    $18.59M
    NUVB annual total long term liabilities is $18.59 million

    Current liabilities

    $58.24M
    NUVB annual total current liabilities is $58.24 million

    Accounts payable

    $6.35M
    NUVB annual accounts payable is $6.35 million

    Debt

    Total debt

    $8.91M
    NUVB annual total debt is $8.91 million

    Total debt 1-year change

    +122.49%
    NUVB annual total debt is up +122.49% year-on-year

    Long term debt

    $969.00K
    NUVB annual long term debt is $969.00 thousand

    Short term debt

    $7.95M
    NUVB annual short term debt is $7.95 million

    Equity & Capital

    Shareholders equity

    $463.79M
    NUVB annual stockholders equity is $463.79 million

    Book value

    $463.79M
    NUVB annual book value is $463.79 million

    Retained earnings

    -$910.74M
    NUVB annual retained earnings is -$910.74 million

    Working capital

    $468.01M
    NUVB annual working capital is $468.01 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$130.41M
    NUVB annual cash flow from operations is -$130.41 million

    Cash from operations 1-year change

    -91.79%
    NUVB annual cash flow from operations is down -91.79% year-on-year

    Cash from investing

    $122.70M
    NUVB annual cash flow from investing activities is $122.70 million

    Cash from investing 1-year change

    +1275.44%
    NUVB annual cash flow from investing activities is up +1275.44% year-on-year

    Cash from financing

    $331.00K
    NUVB annual cash flow from financing activities is $331.00 thousand

    Cash from financing 1-year change

    -47.29%
    NUVB annual cash flow from financing activities is down -47.29% year-on-year

    CAPEX

    CAPEX

    $162.00K
    NUVB annual capital expenditures is $162.00 thousand

    CAPEX 1-year change

    +134.78%
    NUVB annual capital expenditures is up +134.78% year-on-year

    Free Cash Flow

    Free cash flow

    -$130.57M
    NUVB annual free cash flow is -$130.57 million

    Free cash flow 1-year change

    -91.83%
    NUVB annual free cash flow is down -91.83% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    1.42%
    NUVB annual gross profit margin is 1.42%

    Operating margin

    -2128.25%
    NUVB annual operating profit margin is -2128.25%

    Net margin

    -7213.76%
    NUVB annual net profit margin is -7213.76%

    ROA & ROE

    ROA

    -97.74%
    NUVB annual return on assets is -97.74%

    ROE

    -106.27%
    NUVB annual return on equity is -106.27%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NUVB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NUVB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.09
    NUVB price to book ratio is 3.09

    PB ratio Sector rank

    65.37%
    NUVB price to book ratio is higher than 65.37% of companies in Healthcare sector

    PS Ratio

    PS ratio

    80.23
    NUVB price to sales ratio is 80.23

    PS ratio Sector rank

    89.95%
    NUVB price to sales ratio is higher than 89.95% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $747.39M
    NUVB enterprise value is $747.39 million

    Enterprise value Sector rank

    69.99%
    NUVB enterprise value is higher than 69.99% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.72
    NUVB EV/EBITDA is -3.72

    EV/EBITDA Sector rank

    27.22%
    NUVB EV/EBITDA is higher than 27.22% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    9.04
    NUVB annual current ratio is 9.04

    Quick ratio

    9.04
    NUVB annual quick ratio is 9.04

    Leverage

    Debt to equity

    0.02
    NUVB annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    NUVB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    NUVB piotroski f-score is 4

    Altman Z-Score

    4.22
    NUVB altman z-score is 4.22

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 RBC Capital
    Outperform
    Jun 25, 25 JMP Securities
    Market Outperform
    Jun 17, 25 RBC Capital
    Outperform
    Jun 11, 25 Wedbush
    Outperform
    Jun 2, 25 JMP Securities
    Market Outperform
    May 16, 25 Wedbush
    Outperform
    Apr 23, 25 JMP Securities
    Market Outperform
    Mar 12, 25 Jones Trading
    Buy
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Jan 23, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with NUVB included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Nuvation Bio Inc.?
    • Does Nuvation Bio Inc. pay dividends?
    • What sector is Nuvation Bio Inc. in?
    • What industry is Nuvation Bio Inc. in?
    • What country is Nuvation Bio Inc. based in?
    • When did Nuvation Bio Inc. go public?
    • Is Nuvation Bio Inc. in the S&P 500?
    • Is Nuvation Bio Inc. in the NASDAQ 100?
    • Is Nuvation Bio Inc. in the Dow Jones?
    • When was Nuvation Bio Inc.'s last earnings report?
    • When does Nuvation Bio Inc. report earnings?

    What is the ticker symbol for Nuvation Bio Inc.?

    The ticker symbol for Nuvation Bio Inc. is NYSE:NUVB

    Does Nuvation Bio Inc. pay dividends?

    No, Nuvation Bio Inc. does not pay dividends

    What sector is Nuvation Bio Inc. in?

    Nuvation Bio Inc. is in the Healthcare sector

    What industry is Nuvation Bio Inc. in?

    Nuvation Bio Inc. is in the Biotechnology industry

    What country is Nuvation Bio Inc. based in?

    Nuvation Bio Inc. is headquartered in United States

    When did Nuvation Bio Inc. go public?

    Nuvation Bio Inc.'s initial public offering (IPO) was on August 26, 2020

    Is Nuvation Bio Inc. in the S&P 500?

    No, Nuvation Bio Inc. is not included in the S&P 500 index

    Is Nuvation Bio Inc. in the NASDAQ 100?

    No, Nuvation Bio Inc. is not included in the NASDAQ 100 index

    Is Nuvation Bio Inc. in the Dow Jones?

    No, Nuvation Bio Inc. is not included in the Dow Jones index

    When was Nuvation Bio Inc.'s last earnings report?

    Nuvation Bio Inc.'s most recent earnings report was on August 7, 2025

    When does Nuvation Bio Inc. report earnings?

    The next expected earnings date for Nuvation Bio Inc. is November 5, 2025
    On this page